To recover your password please fill in your email address
Please fill in below form to create an account with us
BSc (Med) (hons I), University of Sydney MB BS (hons I), University of Sydney SM (Master of Science in Biostatistics), Harvard University FRACP MD 'Cancer clinical trials: statistical clinical and ethical issues', University of Sydney
Professor John Simes is a Senior Principal Research Fellow, he was the Founding Director of the CTC and is currently Senior Associate Director.
John is a leading international researcher in clinical trials, particularly in cancer, cardiovascular disease, diabetes and neonatal medicine. He co-leads the CTC's team of 200 who collaborate with clinical investigators and other researchers nationally and internationally in a research program aimed at improving health practice and health outcomes through better use of clinical trials research. He has contributed to over 300 peer-reviewed articles, with many having a significant impact on current knowledge and clinical practice.
John is the Founding Director and a current board member of the Sydney Catalyst Translational Research Centre, a virtual centre of cancer researchers in central Sydney and regional NSW. He is a founding member of the Australian Clinical Trials Alliance (ACTA), formed in 2012 to promote effective and evidence based healthcare in Australia through investigator-initiated clinical trials.
John is a practising medical oncologist in neuro-oncology at Royal Prince Alfred Hospital and the Chris O'Brien Lifehouse, and is professor of clinical epidemiology, Faculty of Medicine, University of Sydney. He has taught medical students and postgraduate students at the University of Sydney since 1989. He was awarded the Cancer Achievement Award for lifetime achievement in oncology by the Medical Oncology Group of Australia (2010) and the Distinguished Harvard Alum Award (Biostatistics) from Harvard University (2009) in recognition of his work in research. He is a member of research committees, trials groups and boards, including cancer cooperative groups and safety and data monitoring committees. He has recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences and was named on the Clarivate Analytics 2018 Highly Cited Researchers List.
View John's publications.